Article info
PDFShort report
Rapid fluorescence in situ hybridisation (FISH) for HER2 (ERBB2) assessment in breast and gastro-oesophageal cancer
- Correspondence to Dr Laura J Tafe, Department of Pathology, Dartmouth-Hitchcock Medical Center, One Medical Center, Lebanon, NH 03756, USA; Laura.J.Tafe{at}Hitchcock.org
Citation
Rapid fluorescence in situ hybridisation (FISH) for HER2 (ERBB2) assessment in breast and gastro-oesophageal cancer
Publication history
- Received November 24, 2014
- Revised December 9, 2014
- Accepted December 13, 2014
- First published January 9, 2015.
Online issue publication
June 14, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions